Update
$Icecure Medical(ICCM.US$ FDA to Convene Advisory Panel for Review of Icecure's De Novo Marketing Clearance Request for Prosense®, Decision Expected Early 2025; Aligns With Commercial Readiness Plan
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
